HCN News Team – Highly Capitalized

Monday, January 5, 2026 We Follow The Money.

About HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

NY Cannabis Retailers Double in Number, Push Total Sales Past $2.5B Mark

HCN News Team2026-01-02T07:32:49-08:00January 2nd, 2026|Markets|

NEW YORK – New York state's licensed Cannabis dispensaries grew ...

Czech Republic Rolls Out Limited Cannabis Reforms, Allowing Home Growing and Possession Caps

HCN News Team2026-01-02T06:46:07-08:00January 2nd, 2026|International|

PRAGUE – The Czech Republic ushered in the new year ...

Verano Expands Medical Cannabis Footprint in West Virginia

HCN News Team2025-12-31T06:18:20-08:00December 31st, 2025|MSOs, Retail|

CHICAGO – Verano Holdings Corp. has launched its sixth medical ...

Bipartisan Poll Signals Growing Momentum for Federal Legalization

HCN News Team2025-12-30T04:37:26-08:00December 30th, 2025|Survey|

LOS ANGELES – A fresh survey of registered voters reveals ...

California Allocates $30M in Cannabis Research Grants

HCN News Team2025-12-30T03:26:21-08:00December 30th, 2025|Research|

SACRAMENTO – California's Department of Cannabis Control has disbursed nearly ...

Cannabis Market’s Hidden Scale: New Estimates Point to $90B U.S. Potential

HCN News Team2025-12-29T06:06:52-08:00December 29th, 2025|Insights|

LOS ANGELES – Viridian Capital Advisors' latest Chart of the ...

Republican State AGs Challenge Trump’s Cannabis Rescheduling Directive

HCN News Team2025-12-29T03:59:43-08:00December 29th, 2025|US Politics|

LOS ANGELES – A coalition of Republican attorneys general from ...

Banks Still Hesitant on Expanding Services for Cannabis Businesses Post-Trump Rescheduling Order

HCN News Team2025-12-26T06:48:31-08:00December 26th, 2025|Capital|

LOS ANGELES – President Donald Trump's Executive Order fast-tracked the ...

Atai Gains Nasdaq Biotechnology Index Spot

HCN News Team2025-12-24T03:37:11-08:00December 24th, 2025|Psychedelics|

NEW YORK – AtaiBeckley N.V., the clinical-stage biopharmaceutical firm born ...

Vireo Growth Acquires Eaze, Expands into California and Florida

HCN News Team2025-12-23T09:13:26-08:00December 23rd, 2025|M&As|

MINNEAPOLIS – Vireo Growth Inc. announced a definitive agreement to ...

DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more

HCN Media Group | 171 Pier Avenue, Suite 177, Santa Monica, California, 90405

© Copyright | Highly Capitalized | All Rights Reserved | Website by Vadimages.